APRACLONIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Apraclonidine patents expire, and when can generic versions of Apraclonidine launch?
Apraclonidine is a drug marketed by Rising and is included in one NDA.
The generic ingredient in APRACLONIDINE is apraclonidine hydrochloride. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apraclonidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Apraclonidine
A generic version of APRACLONIDINE was approved as apraclonidine hydrochloride by RISING on March 12th, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for APRACLONIDINE?
- What are the global sales for APRACLONIDINE?
- What is Average Wholesale Price for APRACLONIDINE?
Summary for APRACLONIDINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for APRACLONIDINE |
| What excipients (inactive ingredients) are in APRACLONIDINE? | APRACLONIDINE excipients list |
| DailyMed Link: | APRACLONIDINE at DailyMed |
US Patents and Regulatory Information for APRACLONIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | APRACLONIDINE HYDROCHLORIDE | apraclonidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 077764-001 | Mar 12, 2009 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
